Amaya Advisory Cmte. Will Grapple With Standards For Novel Indication (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executive’s Employment Agreement (Street Insider.com)
Novartis signs $465 million deal with Vanda on schizophrenia drug (Pharma Times)
U.S. Patent Issued for Champions Biotechnology’s Lead Oncology Drug (Reuters)
GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for Votrient (Therapeutics Daily)
Global pricing “hinders European arthritis drug access (PharmaTimes)
RNA repair system discovered in bacteria (R&D)
Healthcare overhaul poised for big step forward (Reuters)
Global pricing “hinders European arthritis drug access” (PharmaTimes)
SUBSCRIBE